Titan Pharmaceuticals
TTNP
#11028
Rank
A$8.86 M
Marketcap
A$6.67
Share price
-3.76%
Change (1 day)
9.20%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -A$4.33 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$6.81 Million, an increase over its 2023 earnings that were of -A$8.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$4.33 Million-36.49%
2024 -A$6.81 Million-15.5%
2023 -A$8.06 Million-45.43%
2022 -A$14.77 Million16.29%
2021 -A$12.7 Million-907.36%
2020 A$1.57 M-106.6%
2019 -A$23.81 Million82.4%
2018 -A$13.05 Million-36.93%
2017 -A$20.7 Million-378.62%
2016 A$7.42 M-145.53%
2015 -A$16.32 Million369.37%
2014 -A$3.48 Million-125.9%
2013 A$13.41 M-177.74%
2012 -A$17.27 Million13.59%
2011 -A$15.2 Million74.37%
2010 -A$8.72 Million3.61%
2009 -A$8.42 Million
2007 -A$26.66 Million12.08%
2006 -A$23.79 Million-28.65%
2005 -A$33.34 Million-10.03%
2004 -A$37.06 Million-6.08%
2003 -A$39.46 Million-14.76%
2002 -A$46.29 Million32.52%
2001 -A$34.93 Million27.55%
2000 -A$27.39 Million62.5%
1999 -A$16.86 Million4.04%
1998 -A$16.2 Million49.33%
1997 -A$10.85 Million-27.88%
1996 -A$15.05 Million13.04%
1995 -A$13.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.07 B-667,515.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$18.28 B-450,830.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-A$0.27 Billion 6,519.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$0.10 B-2,748.84%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$15.55 Million 283.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.48 Billion 11,515.97%๐Ÿ‡บ๐Ÿ‡ธ USA